A quantitative pharmacology model for cannabinoid CB1 receptor mediated by Gi/Gs protein competition

被引:0
|
作者
Yang, Liang [1 ]
Finlay, David B. [2 ]
Green, Hayley M. [2 ]
Zhu, Xiao [3 ]
Glass, Michelle [2 ]
Duffull, Stephen [1 ,4 ]
机构
[1] Univ Otago, Sch Pharm, Otago Pharmacometr Grp, POB 56, Dunedin, New Zealand
[2] Univ Otago, Dept Pharmacol & Toxicol, Dunedin, New Zealand
[3] Fudan Univ, Sch Pharm, Dept Clin Pharm & Pharm Adm, Shanghai, Peoples R China
[4] Certara, Princeton, NJ USA
关键词
CB1; receptor; cyclic AMP; G protein; mathematical model; CONCURRENT STIMULATION; AGONIST; ACTIVATION; EXPRESSION; MECHANISM; G(I/O); G(S);
D O I
10.1111/bph.16293
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and Purpose: Orthosteric agonism of the CB1 receptor normally associates with Gi signalling resulting in a net inhibition of cAMP production. Empirical evidence shows CB1 causes a net cAMP stimulation through Gs coupling under two conditions: co-stimulation with the D-2 receptor and high-level CB1 expression. Two hypotheses have been proposed to account for these paradoxical effects, (1) Gi is consumed by coupling to D-2 or extra CB1 and excess CB1 binds to Gs and (2), the formation of dimers CB1-CB1 or CB1-D-2 switches Gi/Gs preference. This study explored the mechanisms of Gi/Gs preference based on a mathematical model of the CB1 receptor.Experimental Approach: The model was based on Hypothesis 1 and known mechanisms. The model was calibrated to align with multiple types of data (cAMP, Gi dissociation and internalisation). The key step of Hypothesis 1 was examined by simulation from the model. An experiment was proposed to distinguish Hypothesis 1 and 2.Key Results: The model successfully descripted multiple types of data under Hypothesis 1. Simulations from the model indicated that precoupling of G protein with receptors is necessary for this hypothesis. The model designed experiments to distinguish Hypothesis 1 and 2 by increasing Gi & Gs in parallel with CB1 overexpression. The two hypotheses result in distinct cAMP responses.Conclusion and Implications: A mathematical model of CB1-regulated Gi/Gs pathways was developed. It indicated Hypothesis 1 is feasible and G protein precoupling is a key step causing cAMP signalling switch. The model-designed experiments provided guides for future experimentation.
引用
收藏
页码:1324 / 1340
页数:17
相关论文
共 50 条
  • [1] RGS Protein Regulation of CB1 Receptor-Mediated Cannabinoid Behaviors
    Tai, Sherrica
    Kandasamy, Ram
    Barton, Brenna
    Parry, Logan
    Traynor, John R.
    FASEB JOURNAL, 2018, 32 (01):
  • [2] Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
    Blume, Lawrence C.
    Patten, Theresa
    Eldeeb, Khalil
    Leone-Kabler, Sandra
    Ilyasov, Alexander A.
    Keegan, Bradley M.
    O'Neal, Jeremy E.
    Bass, Caroline E.
    Hantgan, Roy R.
    Lowther, W. Todd
    Selley, Dana E.
    Howlett, Allyn C.
    MOLECULAR PHARMACOLOGY, 2017, 91 (02) : 75 - 86
  • [3] Cannabinoid 1 (CB1) Receptor - Pharmacology, Role in Pain and Recent Developments in Emerging CB1 Agonists
    Talwar, Rashmi
    Potluri, Vijay Kumar
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2011, 10 (05) : 536 - 544
  • [4] Structural determinants in the second intracellular loop of the human cannabinoid CB1 receptor mediate selective coupling to Gs and Gi
    Chen, X. P.
    Yang, W.
    Fan, Y.
    Luo, J. S.
    Hong, K.
    Wang, Z.
    Yan, J. F.
    Chen, X.
    Lu, J. X.
    Benovic, J. L.
    Zhou, N. M.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (08) : 1817 - 1834
  • [5] CB1 cannabinoid receptor-mediated cell migration
    Song, ZH
    Zhong, M
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 294 (01): : 204 - 209
  • [6] CB1 cannabinoid receptor-mediated aggressive behavior
    Rodriguez-Arias, Marta
    Navarrete, Francisco
    Daza-Losada, Manuel
    Navarro, Daniela
    Aguilar, Maria A.
    Berbel, Pere
    Minarro, Jose
    Manzanares, Jorge
    NEUROPHARMACOLOGY, 2013, 75 : 172 - 180
  • [7] Pharmacology of cannabinoid CB1 and CB2 receptors
    Pertwee, RG
    PHARMACOLOGY & THERAPEUTICS, 1997, 74 (02) : 129 - 180
  • [8] Chemically distinct ligands promote differential CB1 cannabinoid receptor-Gi protein interactions
    Mukhopadhyay, S
    Howlett, AC
    MOLECULAR PHARMACOLOGY, 2005, 67 (06) : 2016 - 2024
  • [9] Cannabinoid CB1 Receptor Antagonists
    Thomas, Brian F.
    DRUG DEVELOPMENT RESEARCH, 2009, 70 (08) : 525 - 526
  • [10] The CB1 cannabinoid receptor in the brain
    Howlett, AC
    NEUROBIOLOGY OF DISEASE, 1998, 5 (06) : 405 - 416